1. IL-4 signaling, gene transcription regulation, and the control of effector T cells. Boothby M, Mora AL, Aronica MA, Youn J, Sheller JR, Goenka S, Stephenson L (2001) Immunol Res 23(2-3): 179-91
    › Primary publication · 11444383 (PubMed)
  2. IL-4-dependent induction of BCL-2 and BCL-X(L)IN activated T lymphocytes through a STAT6- and pi 3-kinase-independent pathway. Aronica MA, Goenka S, Boothby M (2000) Cytokine 12(6): 578-87
    › Primary publication · 10843732 (PubMed)
  3. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Powell WC, Fingleton B, Wilson CL, Boothby M, Matrisian LM (1999) Curr Biol 9(24): 1441-7
    › Primary publication · 10607586 (PubMed)
  4. Preferential role for NF-kappa B/Rel signaling in the type 1 but not type 2 T cell-dependent immune response in vivo. Aronica MA, Mora AL, Mitchell DB, Finn PW, Johnson JE, Sheller JR, Boothby MR (1999) J Immunol 163(9): 5116-24
    › Primary publication · 10528218 (PubMed)
  5. Paired Stat6 C-terminal transcription activation domains required both for inhibition of an IFN-responsive promoter and trans-activation. Goenka S, Youn J, Dzurek LM, Schindler U, Yu-Lee LY, Boothby M (1999) J Immunol 163(9): 4663-72
    › Primary publication · 10528163 (PubMed)
  6. Lineage-specific differences among CD8+ T cells in their dependence of NF-kappa B/Rel signaling. Mora AL, Chen D, Boothby M, Rubin DH (1999) Eur J Immunol 29(9): 2968-80
    › Primary publication · 10508271 (PubMed)
  7. Essential role of T cell NF-kappa B activation in collagen-induced arthritis. Seetharaman R, Mora AL, Nabozny G, Boothby M, Chen J (1999) J Immunol 163(3): 1577-83
    › Primary publication · 10415062 (PubMed)
  8. Costimulation reverses the defect in IL-2 but not effector cytokine production by T cells with impaired IkappaBalpha degradation. Aune TM, Mora AL, Kim S, Boothby M, Lichtman AH (1999) J Immunol 162(10): 5805-12
    › Primary publication · 10229814 (PubMed)
  9. Stimulus-dependent synergism of the antiapoptotic tumor necrosis factor receptor-associated factor 2 (TRAF2) and nuclear factor kappaB pathways. Lee SY, Kaufman DR, Mora AL, Santana A, Boothby M, Choi Y (1998) J Exp Med 188(7): 1381-4
    › Primary publication · 9763618 (PubMed) · PMC2212489 (PubMed Central)
  10. Regulation of the activity of IFN-gamma promoter elements during Th cell differentiation. Zhang F, Wang DZ, Boothby M, Penix L, Flavell RA, Aune TM (1998) J Immunol 161(11): 6105-12
    › Primary publication · 9834094 (PubMed)